Haemonetics Co. (NYSE:HAE) – Equities researchers at William Blair reduced their Q2 2019 earnings estimates for Haemonetics in a research report issued on Tuesday, August 7th. William Blair analyst B. Weinstein now expects that the medical instruments supplier will post earnings per share of $0.55 for the quarter, down from their prior estimate of $0.56. William Blair also issued estimates for Haemonetics’ Q3 2019 earnings at $0.58 EPS.
Get Haemonetics alerts:
Haemonetics (NYSE:HAE) last announced its quarterly earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.17. The company had revenue of $229.35 million for the quarter, compared to the consensus estimate of $219.52 million. Haemonetics had a net margin of 2.45% and a return on equity of 15.00%.
Top 10 Medical Stocks To Watch For 2019: GSE Systems, Inc.(GVP)
Advisors’ Opinion:
- [By Stephan Byrd]
GSE Systems (NYSEAMERICAN:GVP) SVP Daniel Warren Pugh sold 4,400 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The shares were sold at an average price of $3.75, for a total value of $16,500.00. Following the transaction, the senior vice president now owns 51,613 shares of the company’s stock, valued at approximately $193,548.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Top 10 Medical Stocks To Watch For 2019: ePlus Inc.(PLUS)
Advisors’ Opinion:
- [By Motley Fool Transcribers]
ePlus Inc (NASDAQ:PLUS)Q3 2019 Earnings Conference CallFeb. 06, 2019, 4:30 p.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Stephan Byrd]
ePlus (NASDAQ:PLUS) Director Eric D. Hovde sold 27,995 shares of the firm’s stock in a transaction on Wednesday, June 6th. The stock was sold at an average price of $94.23, for a total value of $2,637,968.85. Following the transaction, the director now owns 23,301 shares in the company, valued at $2,195,653.23. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
- [By Max Byerly]
Uniplan Investment Counsel Inc. reduced its stake in ePlus (NASDAQ:PLUS) by 1.1% during the 1st quarter, HoldingsChannel reports. The fund owned 116,594 shares of the software maker’s stock after selling 1,335 shares during the period. Uniplan Investment Counsel Inc.’s holdings in ePlus were worth $9,059,000 at the end of the most recent reporting period.
- [By Ethan Ryder]
Tech Data (NASDAQ: TECD) and ePlus (NASDAQ:PLUS) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.
- [By Lisa Levin]
Companies Reporting After The Bell
Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion.
Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million.
Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion.
Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million.
Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million.
Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million.
Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million.
Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million.
DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion.
8×8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million.
Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million.
ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion.
Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion.
Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million.
Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million.
Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue
Top 10 Medical Stocks To Watch For 2019: Innovative Industrial Properties, Inc. (IIPR)
Advisors’ Opinion:
- [By Sean Williams]
Lastly, this marijuana skeptic likes Innovative Industrial Properties (NYSE:IIPR), a U.S.-based real estate investment trust (REIT).
The beauty of the REIT model is that it tends to produce predictable cash flow at roughly fixed costs. A REIT will acquire land and buildings within a specific industry of focus, then look to lease these assets out for a long period of time. Later, these assets can be disposed of for a profit, should the REIT choose.
- [By Dan Caplinger]
Marijuana stocks have become exceedingly popular, but not everyone feels comfortable investing directly in the companies that produce and grow cannabis. Instead, some prefer to look at the companies that are in the business of helping marijuana producers maximize their growth business. Scotts Miracle-Gro (NYSE:SMG) provides fertilizers and equipment that individual and commercial operations can use to boost cannabis production, while Innovative Industrial Properties (NYSE:IIPR) is a real estate investment trust designed to help cannabis companies find the space they need while meeting all the regulatory requirements surrounding marijuana production facilities.
- [By Keith Speights]
Canopy Growth wouldn’t be the first cannabis-focused REIT if it decides to move forward with Linton’s idea. Innovative Industrial Properties (NYSE:IIPR) owns properties in 10 U.S. states. It leases these properties to businesses operating in the medical cannabis industry.
- [By Keith Speights]
Two cannabis-focused biotechs, Insys Pharmaceuticals (NASDAQ:INSY) and GW Pharmaceuticals (NASDAQ:GWPH), ranked among the five best-performing marijuana stocks last month. CannTrust Holdings (NYSE:CTST) and Village Farms International (NASDAQ:VFF) made the list for February but aren’t in the top tier of Canadian marijuana producers. And one U.S.-based company that isn’t a biotech landed in the top five as well — Innovative Industrial Properties (NYSE:IIPR).
- [By Dan Caplinger]
The stock market jumped on Friday, sending the Dow Jones Industrial Average to gains of over 400 points as investors seemed pleased with news out of Washington. The federal government averted another potential shutdown, and building positive momentum made some market participants fearful that they could miss out if stock indexes keep heading upward toward record levels. Some positive news on the earnings front for certain high-profile stocks also improved sentiment. Arista Networks (NYSE:ANET), Talend (NASDAQ:TLND), and Innovative Industrial Properties (NYSE:IIPR) were among the top performers. Here’s why they did so well.
Top 10 Medical Stocks To Watch For 2019: Banco De Chile(BCH)
Advisors’ Opinion:
- [By Joseph Griffin]
Shares of Banco de Chile (NYSE:BCH) have been given a consensus recommendation of “Sell” by the seven analysts that are currently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a sell recommendation and two have assigned a hold recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $91.00.
- [By Max Byerly]
Bitcoin Cash (CURRENCY:BCH) traded 3.3% lower against the US dollar during the one day period ending at 23:00 PM E.T. on August 25th. One Bitcoin Cash coin can now be bought for about $520.83 or 0.07863301 BTC on popular exchanges including Mercatox, BTCC, Bit2C and xBTCe. Bitcoin Cash has a market capitalization of $9.02 billion and approximately $268.90 million worth of Bitcoin Cash was traded on exchanges in the last day. Over the last week, Bitcoin Cash has traded down 5.9% against the US dollar.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Banco de Chile (BCH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Bitcoin Cash (CURRENCY:BCH) traded down 1.5% against the dollar during the 24 hour period ending at 19:00 PM E.T. on May 19th. During the last week, Bitcoin Cash has traded down 18.1% against the dollar. One Bitcoin Cash coin can now be bought for $1,184.65 or 0.14390800 BTC on major exchanges including fex, Koinex, DSX and Bitfinex. Bitcoin Cash has a total market cap of $20.30 billion and approximately $598.31 million worth of Bitcoin Cash was traded on exchanges in the last 24 hours.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Banco de Chile (BCH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Banco de Chile (NYSE: BCH) and Cr AGRICOLE S A/ADR (OTCMKTS:CRARY) are both large-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.
Top 10 Medical Stocks To Watch For 2019: Koss Corporation(KOSS)
Advisors’ Opinion:
- [By Money Morning Staff Reports]
However, Seven Star’s gains are already on the books. After looking at last week’s top performing penny stocks, we’ll show you a penny stock on the verge of jumping over 70%…
Penny Stock Current Share Price Last Week’s Gain
Seven Stars Cloud Group Inc. (Nasdaq: SSC) $4.49 175.13%
Alliance MMA Inc. (Nasdaq: AMMA) $0.37 121.05%
India Globalization Capital Inc. (NYSE: IGC) $1.14 74.38%
Obalon Therapeutics Inc. (Nasdaq: OBLN) $3.23 63.16%
Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.56 55.76%
Atlanticus Holdings Corp. (Nasdaq: ATLC) $2.85 43.55%
Research Frontiers Inc. (Nasdaq: REFR) $1.28 41.37%
Koss Corp. (Nasdaq: KOSS) $4.08 41.28%
GLG Life Tech Corp. (TSE: GLG) $0.88 33.90%
Geron Corp. (Nasdaq: GERN) $4.76 32.40%While those gains are already in the book, you don’t have to miss out on the next penny stocks to soar.
- [By Lisa Levin] Gainers
Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday. - [By Lisa Levin] Gainers
Loxo Oncology, Inc. (NASDAQ: LOXO) rose 17.1 percent to $163.30 in pre-market trading as the company disclosed that LOXO-292 Phase 1 trial abstract was selected for 'Best of ASCO'.
CytomX Therapeutics, Inc. (NASDAQ: CTMX) rose 11.5 percent to $27.15 in pre-market trading after the company announced presentations at the 2018 ASCO Annual Meeting.
Check-Cap Ltd. (NASDAQ: CHEK) rose 12.3 percent to $5.47 in pre-market trading after reporting narrower-than-expected Q1 loss.
Flotek Industries, Inc. (NYSE: FTK) shares rose 7.1 percent to $3.62 in the pre-market trading session.
Baozun Inc. (NASDAQ: BZUN) shares rose 5.8 percent to $47.65 in pre-market trading after reporting Q1 results.
World Wrestling Entertainment, Inc. (NYSE: WWE) rose 5.5 percent to $46.00 in pre-market trading.
Williams Partners L.P. (NYSE: WPZ) rose 5.3 percent to $40.50 in pre-market trading after The Williams Companies, Inc. (NYSE: WMB) announced agreement to acquire all public equity of Williams Partners in a $10.5 billion deal.
Koss Corporation (NASDAQ: KOSS) shares rose 4.6 percent to $2.72 in pre-market trading after surging 12.55 percent on Wednesday.
Enphase Energy, Inc. (NASDAQ: ENPH) rose 4.5 percent to $5.85 in pre-market trading after gaining 5.66 percent on Wednesday.
Farmer Bros. Co. (NASDAQ: FARM) rose 4.1 percent to $27 in pre-market trading after climbing 7.90 percent on Wednesday.
Kosmos Energy Ltd. (NYSE: KOS) rose 4 percent to $7.70 in pre-market trading.
Top 10 Medical Stocks To Watch For 2019: SPDR Wells Fargo Preferred Stock ETF (PSK)
Advisors’ Opinion:
- [By Max Byerly]
PrairieSky Royalty Ltd (TSE:PSK) has earned a consensus recommendation of “Buy” from the twelve brokerages that are covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is C$32.99.
- [By Ethan Ryder]
PrairieSky Royalty (TSE:PSK)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as C$28.50 and last traded at C$28.40, with a volume of 395241 shares changing hands. The stock had previously closed at C$28.32.
- [By Shane Hupp]
The firm also recently declared a monthly dividend, which was paid on Thursday, February 7th. Shareholders of record on Monday, February 4th were given a $0.20 dividend. This represents a $2.40 annualized dividend and a yield of 5.76%. The ex-dividend date was Friday, February 1st.
TRADEMARK VIOLATION NOTICE: “SPDR Wells Fargo Preferred Stock ETF (PSK) Shares Sold by Regal Investment Advisors LLC” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this article on another domain, it was stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/4139767/spdr-wells-fargo-preferred-stock-etf-psk-shares-sold-by-regal-investment-advisors-llc.html.
About SPDR Wells Fargo Preferred Stock ETF
- [By Shane Hupp]
LPL Financial LLC decreased its position in shares of SPDR Wells Fargo Preferred Stock ETF (NYSEARCA:PSK) by 23.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 138,573 shares of the company’s stock after selling 41,937 shares during the quarter. LPL Financial LLC’s holdings in SPDR Wells Fargo Preferred Stock ETF were worth $6,021,000 as of its most recent filing with the SEC.
- [By Max Byerly]
SPDR Wells Fargo Preferred Stock ETF (NYSEARCA:PSK) announced a monthly dividend on Monday, September 3rd, Wall Street Journal reports. Investors of record on Wednesday, September 5th will be given a dividend of 0.20 per share on Monday, September 10th. This represents a $2.40 annualized dividend and a dividend yield of 5.51%. The ex-dividend date of this dividend is Tuesday, September 4th.
Top 10 Medical Stocks To Watch For 2019: OSI Systems, Inc.(OSIS)
Advisors’ Opinion:
- [By Max Byerly]
Clearline Capital LP lessened its position in OSI Systems, Inc. (NASDAQ:OSIS) by 62.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 51,099 shares of the technology company’s stock after selling 83,849 shares during the period. OSI Systems comprises 2.6% of Clearline Capital LP’s portfolio, making the stock its 15th largest holding. Clearline Capital LP’s holdings in OSI Systems were worth $3,951,000 at the end of the most recent reporting period.
- [By Joseph Griffin]
Xilinx (NASDAQ:XLNX) and OSI Systems (NASDAQ:OSIS) are both computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.
- [By Shane Hupp]
Get a free copy of the Zacks research report on OSI Systems (OSIS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Medical Stocks To Watch For 2019: Golden Entertainment, Inc.(GDEN)
Advisors’ Opinion:
- [By Logan Wallace]
Shares of Golden Entertainment Inc (NASDAQ:GDEN) have received a consensus rating of “Hold” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $36.67.
- [By Logan Wallace]
Golden Entertainment Inc (NASDAQ:GDEN) shares traded up 7.2% during mid-day trading on Tuesday . The company traded as high as $25.31 and last traded at $25.29. 501,759 shares traded hands during mid-day trading, an increase of 47% from the average session volume of 341,759 shares. The stock had previously closed at $23.59.
- [By Shane Hupp]
News coverage about Golden Entertainment (NASDAQ:GDEN) has been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Golden Entertainment earned a news sentiment score of 0.23 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.5212527362401 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Top 10 Medical Stocks To Watch For 2019: Shenandoah Telecommunications Co(SHEN)
Advisors’ Opinion:
- [By Shane Hupp]
Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
WINTON GROUP Ltd purchased a new stake in Shenandoah Telecommunications (NASDAQ:SHEN) during the first quarter, Holdings Channel reports. The firm purchased 24,122 shares of the utilities provider’s stock, valued at approximately $868,000.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Shenandoah Telecommunications (SHEN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Medical Stocks To Watch For 2019: ESSA Pharma Inc.(EPIX)
Advisors’ Opinion:
- [By Stephan Byrd]
Get a free copy of the Zacks research report on ESSA Pharma (EPIX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Get a free copy of the Zacks research report on ESSA Pharma (EPIX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on ESSA Pharma (EPIX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lisa Levin]
Losers
Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
Arcadia Biosciences, Inc. (N